Clinical trials
Phase 3 Psychotic Disorders trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2017 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Not yet recruiting | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Oxford | 3 |
| ACADIA Pharmaceuticals Inc. | 1 |
| Alkermes, Inc. | 1 |
| Eli Lilly and Company | 1 |
| European Group for Research In Schizophrenia | 1 |
| Janssen-Cilag International NV | 1 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 9 |
| Schizophrenia | 4 |
| Alzheimer Disease | 2 |
| Cognitive Dysfunction | 1 |
| Corticobasal Degeneration | 1 |
| Dementia | 1 |
| Dementia, Vascular | 1 |
| Hallucinations | 1 |
| Lewy Body Disease | 1 |
| Supranuclear Palsy, Progressive | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.